ETF Series Solutions Trust Range Cancer Therapeutics ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNCR and other ETFs, options, and stocks.

About CNCR

CNCR tracks an equal-weighted index of companies currently developing oncology drugs or selling cancer therapeutic products. 

Index-Tracked
Range Oncology Therapeutics TR USD
Index-TrackedRange Oncology Therapeutics TR USD
Category
Health
CategoryHealth
Number of holdings
77
Number of holdings77
Inception Date
Oct 13, 2015
Inception DateOct 13, 2015

What's in this fund

Sectors

As of January 17, 2025
Healthcare100.00%

Top 10 Holdings (23.22% of total assets)

As of January 17, 2025
NameSymbol% Assets
Recursion PharmaceuticalsRXRX3.40%
Ginkgo BioworksDNA2.99%
Compass TherapeuticsCMPX2.62%
ExelixisEXEL2.26%
Vor BiopharmaVOR2.27%
Blueprint MedicinesBPMC2.19%
Bristol-Myers SquibbBMY1.94%
PrecigenPGEN1.91%
ZymeworksZYME1.90%
Monte Rosa TherapeuticsGLUE1.74%

CNCR Key Statistics

AUM
10.05M
AUM10.05M
Price-Earnings ratio
-2.04
Price-Earnings ratio-2.04
30-Day yield
-0.66
30-Day yield-0.66
Average volume
2.92K
Average volume2.92K
High today
$12.35
High today$12.35
Low today
$12.08
Low today$12.08
Open price
$12.29
Open price$12.29
Volume
2.72K
Volume2.72K
52 Week high
$17.96
52 Week high$17.96
52 Week low
$11.38
52 Week low$11.38
Expense ratio
0.79
Expense ratio0.79
View Prospectus and Reports

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.